Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy With Cataplexy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05687903
What this trial is testing

TAK-861 in Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 112
Not applicableStudy completedNCT05314556
What this trial is testing

Group Psychotherapy in Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Cantonal Hospital of St. Gallen 10
Not applicableStudy completedNCT04306952
What this trial is testing

Awareness and Self-Compassion Enhancing Narcolepsy Treatment

Who this might be right for
NarcolepsyNarcolepsy Without CataplexyNarcolepsy With Cataplexy
Northwestern University 60
Not applicableTemporarily pausedNCT04419792
What this trial is testing

'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'

Who this might be right for
NarcolepsyNarcolepsy 1Narcolepsy Type 1+4 more
University of Dublin, Trinity College 70
Testing effectiveness (Phase 2)Looking for participantsNCT07633301
What this trial is testing

TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

Who this might be right for
Narcolepsy Type 1
Takeda 92
Large-scale testing (Phase 3)Study completedNCT02611687
What this trial is testing

Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period

Who this might be right for
Narcolepsy With CataplexyNarcolepsy Without Cataplexy
Bioprojet 110
Testing effectiveness (Phase 2)Study completedNCT05687916
What this trial is testing

TAK-861 in Participants With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Takeda 71
Not applicableStudy completedNCT05709873
What this trial is testing

Narcolepsy Nightmare Study

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+2 more
Northwestern University 7
Large-scale testing (Phase 3)Study completedNCT06505031
What this trial is testing

TAK-861 in People With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 105
Testing effectiveness (Phase 2)Study completedNCT00075959
What this trial is testing

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Who this might be right for
Intracerebral Hemorrhage
AstraZeneca 600
Large-scale testing (Phase 3)Study completedNCT01399606
What this trial is testing

Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)

Who this might be right for
NarcolepsyCataplexy
Bioprojet 102
Testing effectiveness (Phase 2)Study completedNCT04923594
What this trial is testing

Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

Who this might be right for
NarcolepsyExcessive Daytime SleepinessCataplexy Narcolepsy
NLS Pharmaceutics 67
Not applicableStudy completedNCT05375890
What this trial is testing

Clinical and Neurophysiological Characteristics of Narcolepsy

Who this might be right for
Narcolepsy Type 1
I.M. Sechenov First Moscow State Medical University 89
Testing effectiveness (Phase 2)Study completedNCT02512588
What this trial is testing

Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Who this might be right for
Idiopathic HypersomniaNarcolepsy Without Cataplexy
Balance Therapeutics 120
Testing effectiveness (Phase 2)Study completedNCT05055024
What this trial is testing

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Who this might be right for
Narcolepsy With CataplexyNarcolepsyNarcolepsy Without Cataplexy
NLS Pharmaceutics 52
Not applicableNo Longer AvailableNCT03433131
What this trial is testing

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Who this might be right for
Narcolepsy Without CataplexyNarcolepsy With Cataplexy
Harmony Biosciences Management, Inc.
Large-scale testing (Phase 3)Study completedNCT00078312
What this trial is testing

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Who this might be right for
NarcolepsySleep Apnea, ObstructiveSleep Apnea Syndromes+1 more
Cephalon 328
Large-scale testing (Phase 3)Study completedNCT03030599
What this trial is testing

The Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy With Cataplexy
Jazz Pharmaceuticals 201
Large-scale testing (Phase 3)Study completedNCT05059223
What this trial is testing

Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 90
Large-scale testing (Phase 3)Study completedNCT01800045
What this trial is testing

Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)

Who this might be right for
Narcolepsy With CataplexyExcessive Daytime Sleepiness
Bioprojet 103
Next Page